Stella Pharma Corporation (TYO:4888)

Stella Pharma Revenue

Stella Pharma had revenue of 92.00M JPY in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to 323.00M, down -67.44% year-over-year. In the fiscal year ending March 31, 2026, Stella Pharma had annual revenue of 323.00M, down -66.39%. That makes Stella Pharma the 42,342nd largest company in the world by revenue and 3,849th in Japan.

• Revenue: 323.00M
• Revenue Growth: -67.44%
• P/S Ratio: 46.09
• Revenue / Employee: 6.87M
• Employees: 47
• Market Cap: 14.89B

Revenue Chart

Chart

Chart

Revenue by Geography

• China 629.97M 65.5%
• Japan 331.09M 34.5%

Fiscal year ended Mar 31, 2024 See the full Stella Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	323.00M	-638.00M	-66.39%
Mar 31, 2025	961.00M	692.00M	257.25%
Mar 31, 2024	269.00M	40.00M	17.47%
Mar 31, 2023	229.00M	129.00M	129.00%
Mar 31, 2022	100.00M	-105.00M	-51.22%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error